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Patients with small bowel ostomies (ie, jejunostomies or ileos-
tomies) are highly susceptible to fluid and electrolyte abnor-
malities.1,2 Among the electrolytes, ileostomy losses of sodium 
are the greatest at levels of 100–120 mEq/L/d.1,3 A sodium defi-
cit of 7% and a significant decrease in urinary sodium excretion 
have been seen in otherwise healthy adult patients with ileosto-
mies.4 Patients with high-output stomas or long-established 
ileostomies are at a greater risk for sodium losses, potentially 
leading to total body sodium depletion (TBSD). While a precise 
measure of total body sodium (TBS) levels is challenging, 
many have used the definition of TBSD as a urine sodium level 
<10 mmol/L, thus reflecting strong retention of the body’s 
sodium reserves. Sodium losses are of greater concern in infants 
and young children due to proportionately greater obligatory 
losses and immature renal conservation of fluid and electrolytes 
as well as special requirements for growth.5,6
Failure to thrive (FTT) associated with TBSD has been 
reported in neonates with ileostomies.5,7 In fact, TBSD results 
in an inability to become anabolic despite energy delivery 
exceeding energy needs. Thus, it is a common practice to check 
urine sodium levels in neonates, with expected sodium losses 
demonstrating poor weight gain,5,7 and to supplement sodium 
in those with documented depletion. However, FTT associated 
with TBSD has not been well described outside of the neonatal 
period. The following 4 cases illustrate our experience of 
weight loss in the presence of TBSD in children and young 
adults with an ileostomy.
Methods
A retrospective screening of all children with a small bowel 
ostomy cared for in our Children’s Intestinal Rehabilitation 
Program from 2010–2012 was completed. All children beyond 
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Abstract
Patients with high-output small bowel ostomies are at risk for total body sodium depletion (TBSD), defined as a urine sodium level 
<10 mmol/L. Failure to thrive (FTT) as a consequence of TBSD has been reported in neonates with ileostomies; however, this has not 
been well described in older children. The records of all children beyond the age of infancy with a small bowel ostomy cared for in our 
Children’s Intestinal Rehabilitation Program from 2010–2012 were reviewed. Four patients between the ages of 18 months and 19 years 
were identified as having TBSD. All 4 patients experienced unintentional weight loss, despite adequate energy intake based on calculated 
needs, which was associated with a urine sodium level ≤10 mmol/L. With the supplementation of sodium, either enteral or intravenous, 
all patients demonstrated improved weight gain and correction of TBSD. The following cases suggest that the relationship between TBSD 
and FTT may extend well beyond the neonatal period and possibly into adulthood. We advise that patients of all ages with high stoma 
output have routine urine sodium levels checked, particularly in the setting of weight loss or poor gain. Furthermore, instances of TBSD 
should be treated with sodium supplementation. Further research is needed to better understand the relationship between TBSD and FTT 
and to establish intervention guidelines. (Nutr Clin Pract. 2014;29:397-401)
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the age of infancy with >1 episode of TBSD were selected for 
this study. Patients with renal insufficiency were excluded 
from the study, as their urine sodium levels might not be a good 
reflection of TBS levels. Of the 11 patients with a small bowel 
ostomy, 4 were identified as having TBSD, defined as a urine 
sodium level <10 mmol/L, and comprised the patients reported 
in this series. The 7 patients excluded did not have regular 
urine sodium levels checked; therefore, TBS status was 
unknown. The study was approved by our hospital’s institu-
tional review board (HUM00066381).
Case Presentations
Case 1
The first case was a 19-year-old female patient with intestinal 
failure secondary to ulcerative colitis after total colectomy 
with J-pouch and ileoanal anastomosis, multiple small bowel 
resections, and creation of an end ileostomy due to several 
small bowel obstructions. The patient presented to our clinic 
with a 2.2-kg weight loss and a body mass index (BMI) of 17 
kg/m2, despite receiving 130% of her estimated energy needs 
from a combination of parenteral nutrition (PN) and reported 
oral intake based on a 24-hour recall, following a 3-month 
period of persistent weight gain. The amount of sodium in her 
PN regimen was 161 mEq (3.4 mEq/kg/d), the reported ileos-
tomy output was approximately 2200 mL/d (46 mL/kg/d), and 
serum and urine sodium levels were 138 and <10 mmol/L, 
respectively. After clinical evaluation, caloric provision from 
PN was determined to be appropriate, but the patient was 
instructed to add 1.5 teaspoons (154 mEq of sodium) of table 
salt to foods daily, bringing the total supplemental sodium 
intake to 315 mEq (6.6 mEq/kg/d). One month later, the patient 
returned to the clinic and demonstrated a weight gain of 4.8 kg, 
BMI of 18.8 kg/m2, urine sodium level of 129 mmol/L, and a 
stable serum sodium level and oral intake. The reported ileos-
tomy output was approximately 2600 mL (50 mL/kg/d). With 
the long-term goal of weaning the patient off PN in mind, PN 
was decreased from 6 to 5 d/wk to decrease energy input by 
approximately 15%, subsequently decreasing her supplemen-
tal sodium intake to a daily average of 269 mEq (5.1 mEq/
kg/d). Approximately 1 month later, the patient demonstrated a 
further weight gain of 1.2 kg and an improved BMI of 19.2 kg/
m2, with a urine sodium level of 10 mmol/L. The serum sodium 
level was 139 mmol/L. She denied any changes in oral intake 
or ileostomy output. The caloric content of PN was decreased 
by another 20%, reducing PN to 4 d/wk and subsequently 
decreasing the supplemental sodium intake to a daily average 
of 246 mEq (4.6 mEq/kg/d). The following month, she demon-
strated a weight loss of 3.2 kg and a BMI of 18 kg/m2, despite 
reporting an “excellent appetite.” Her urine sodium level was 
requested but never received due to noncompliance. The serum 
sodium level was 137 mmol/L, and the estimated ileostomy 
output was approximately 2800 mL (56 mL/kg/d). PN energy 
input was increased by 10%, PN sodium provision was 
unchanged, and the addition of salt to foods was reinforced due 
to suspicion of noncompliance. Approximately 2 months later, 
the patient demonstrated a weight gain of 5.1 kg, BMI of 19.8 
kg/m2, and serum and urine sodium levels of 139 and 79 
mmol/L, respectively. Furthermore, the patient reported that 
she had not been infusing PN for approximately 1 month. Due 
to a combination of noncompliance with PN, adequate weight 
gain, improved oral intake, and appropriate laboratory results, 
the patient’s supplemental PN was discontinued. Three weeks 
later, the patient’s weight was down 3.3 kg with a BMI of 18.7 
kg/m2, and she reported no changes in oral intake. The serum 
sodium level was 141 mmol/L, and the urine sodium level 
decreased to 10 mmol/L. Ileostomy output was approximately 
2200 mL (42 mL/kg/d). To provide more consistent and precise 
sodium supplementation, the patient was prescribed sodium 
chloride tablets at a dose of 120 mEq of sodium (2.3 mEq/
kg/d). The following month, the patient demonstrated a 2.3-kg 
weight gain with a BMI of 19.5 kg/m2. Her urine sodium level 
increased to 137 mmol/L, while the serum sodium level 
remained stable. Over the next 8 months, the patient main-
tained her weight and a BMI >19 kg/m2, and the decision was 
made to take down her ileostomy. One month after the opera-
tion, the patient demonstrated a weight loss of 4.4 kg. Serum 
sodium and urine sodium levels were collected and were 136 
and 10 mmol/L, respectively. It was recommended that she 
resume the sodium chloride tablets per her previous dose of 
120 mEq (2.3 mEq/kg/d), and 5 days later, she had an improved 
urine sodium level of 163 mmol/L. Her weight was not 
obtained at that time; however, 3 weeks later, her weight 
increased by 2.2 kg. Figure 1 depicts urine sodium levels in 
relation to weight from the time of the initial documented 
TBSD to the time that the patient was being followed for FTT.
Case 2
The second case was a 12-year-old female patient with intes-
tinal failure secondary to dysmotility with chronic intestinal 
pseudo-obstruction who underwent a colectomy and creation 
of an end ileostomy. The patient presented to our clinic for a 
routine visit with an unexpected 5.2-kg weight loss and a BMI 
of 15.1 kg/m2. Both serum sodium and urine sodium levels 
were collected and were 135 and <10 mmol/L, respectively. 
At that time, the patient was admitted to the hospital and 
began receiving 154 mEq (4.5 mEq/kg/d) of sodium supple-
mentation via an enteral bolus of 250 mL of normal saline 
4 times daily. Additionally, the patient was started on a combi-
nation of enteral feeds and intravenous hydration of D5 
0.45NS titrated to a fluid goal of 75 mL/h. Over the first 
4 days of admission, ileostomy output averaged 2100 mL 
(59 mL/kg/d). The electrolyte content of ileostomy output was 
115 mmol/L of sodium, >10 mmol/L of potassium, and 
35 mmol/L of chloride, showing an expected high sodium 
loss. On hospital day 5, her repeat urine sodium level was 
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203 mmol/L, the patient gained 0.67 kg, and her BMI increased 
to 16.3 kg/m2. After a 3-week hospital course, the patient was 
discharged home on a modified oral diet, controlling ostomy 
output, and PN containing 185 mEq (4.7 mEq/kg) of sodium. 
After the patient was discharged, her repeat urine sodium level 
was requested but not received due to noncompliance. Over 
the next 10 months, the energy content and electrolyte compo-
sition of her home PN were slowly weaned as oral intake 
increased. The patient then presented to the clinic with an 
unexpected 2.5-kg weight loss with a BMI of 18 kg/m2. Both 
serum sodium and urine sodium levels were collected and 
were 136 and <10 mmol/L, respectively. The sodium content 
of PN was increased from 134 mEq (3 mEq/kg) to 181 mEq 
(4.2 mEq/kg), and PN calories were increased by 10%. 
Ileostomy output was not quantified at home due to the 
patient’s refusal. Two weeks later, both serum sodium and 
urine sodium levels were collected and were 140 and 
154 mmol/L, respectively, and the patient gained 1.1 kg (BMI, 
18.4 kg/m2). See Table 1 for a chronological display of this 
patient’s serum sodium level, urine sodium level, and weight.
Case 3
The third case was a 19-year-old female patient with a history 
of Hirschsprung disease and gastrointestinal dysmotility with 
an end ileostomy and long-term PN dependence. The patient 
presented to our clinic with an unexpected weight loss of 
1.1 kg and a BMI of 16.2 kg/m2, despite receiving 100% of her 
estimated energy needs via PN in addition to minimal oral 
intake. Ostomy output was not quantified at home due to the 
patient’s refusal. Serum sodium and urine sodium levels were 
139 and 10 mmol/L, respectively. The amount of sodium in PN 
was increased by 20 mEq to maximize the sodium concentra-
tion to 154 mEq/L, providing a total of 385 mEq (9 mEq/kg); 
however, the PN energy content was left unchanged. Three 
weeks later, the patient presented with a 3.75-kg weight gain 
and an improved BMI of 17.6 kg/m2 and denied any change in 
her oral intake. At that time, serum sodium and urine sodium 
levels were 142 and 86 mmol/L, respectively. The patient was 
seen in the clinic 5 weeks later and gained another 4.3 kg 
(BMI, 19.3 kg/m2) and reported improved oral intake. The 
serum sodium level was 140 mmol/L, and the urine sodium 
level was requested but never received due to noncompliance. 
After clinical evaluation, caloric input from PN was decreased 
by 20%, but the sodium content was left stable at 385 mEq 
Figure 1. Graphic display of urine sodium levels (broken line) 
in relation to body weight (black solid line) for case 1. Note the 
relationship between each loss in body weight with a decline in 
the urine sodium level. Days represent the range of laboratory 
results and weights available during the time that the patient was 
being followed for failure to thrive.
Table 1. Chronological Display of Changes in Each Patient’s 






Level, mmol/L Weight, kg
Case 1
1/25/11 141 13 49.7
2/16/11 138 <10 47.5
3/16/11 138 129 52.3
4/20/11 139 10 53.5
5/25/11 137 N/A 50.3
7/13/11 139 79 55.4
8/4/11 141 10 52.1
8/31/11 141 137 54.4
6/10/12 136 10 51.1
6/15/12 140 163 N/A
7/6/12 N/A N/A 53.3
Case 2
5/11/11 136 126 39.8
7/6/11 135 <10 34.6
7/11/11 139 203 35.3
7/12/11 138 96 N/A
2/15/12 N/A N/A 45.9
5/2/12 136 <10 43.4
5/15/12 140 154 44.5
7/11/12 138 79 46.9
Case 3
2/3/12 139 130 44
2/27/12 139 10 42.95
3/19/12 142 86 46.7
4/25/12 140 N/A 51
6/8/12 142 111 N/A
7/9/12 N/A N/A 52.3
Case 4
12/4/11 144 98 7.82
12/16/11 132 <10 7.56
1/11/12 N/A 89 8.41
3/29/12 N/A N/A 8.98
5/24/12 137 <10 8.73
6/28/12 N/A 46 9.1
7/31/12 N/A <5 N/A
8/10/12 143 80 9.14
N/A, not available.
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(7.5 mEq/kg). Approximately 6 weeks later, laboratory results 
were collected at an outside facility, and serum and urine 
sodium levels were 142 and 111 mmol/L, respectively. A 
weight check was requested but never received. Approximately 
1 month later, the patient canceled her follow-up visit to our 
clinic but reported that her weight at that time was up by 1.3 kg 
with an improved BMI of 19.6 kg/m2. See Table 1 for a chrono-
logical display of this patient’s serum sodium level, urine 
sodium level, and weight.
Case 4
The fourth case was an 18-month-old male patient with a his-
tory of Hirschsprung disease complicated by a stricture at his 
anastomosis. He underwent an extensive lysis of small bowel 
adhesions and loop ileostomy formation. He presented to our 
clinic with a 0.3-kg weight loss and weight for length at the 
seventh percentile, despite receiving 100% of his minimum 
estimated energy needs via gastrostomy tube feedings. The 
sodium content of enteral nutrition (EN) was 13.8 mEq 
(1.8 mEq/kg), the estimated ileostomy output was 280 mL 
(37 mL/kg/d), and serum sodium and urine sodium levels were 
132 and <10 mmol/L, respectively. Due to a low serum CO
2
 
level, he was prescribed 15 mEq of sodium bicarbonate twice 
daily (4 mEq/kg/d) for the treatment of his TBSD. Additionally, 
EN calories were increased by 10%, bringing the total sodium 
intake to 45 mEq (6 mEq/kg). One month later, he returned to 
the clinic and demonstrated a 0.85-kg weight gain, and the 
urine sodium level was 89 mmol/L. The serum sodium level 
and estimated ileostomy output were not obtained. The total 
sodium intake from EN and sodium bicarbonate supplements 
was 45 mEq (5.4 mEq/kg). Six weeks later, the patient was 
admitted to the hospital for 15 days secondary to viral-associ-
ated respiratory distress. At admission, his weight was up 
0.3 kg, the total sodium intake was 46 mEq (5.3 mEq/kg/d), 
and the serum sodium level was 145 mmol/L. His urine sodium 
level was not collected. During his admission, sodium bicar-
bonate was held due to his nil per os status and was not resumed 
at discharge secondary to appropriate weight gain and labora-
tory results. At discharge, the patient’s weight was down 0.2 
kg. EN provided 1.9 mEq/kg of sodium daily. Two months 
later, he was seen in the clinic and demonstrated poor weight 
gain and had serum and urine sodium levels of 137 and 
<10 mmol, respectively. Sodium bicarbonate was resumed at 
the previous dose of 15 mEq twice daily (3.5 mEq/kg/d), bring-
ing the total sodium intake to 48 mEq (5.5 mEq/kg). One 
month later, the patient demonstrated a 0.4-kg weight gain and 
an improved urine sodium level of 46 mmol/L. The following 
month, the urine sodium level was collected at an outside labo-
ratory and was <5 mmol/L, despite the patient’s mother deny-
ing changes in the EN regimen, ileostomy output, or weight. 
Subsequently, the sodium bicarbonate dose was increased to 
25 mEq twice daily, increasing the total sodium intake to 68 
mEq (7.5 mEq/kg). A week later, the patient presented to the 
clinic, and despite an improved urine sodium level of 80 
mmol/L, his weight remained unchanged. He is currently sta-
ble and awaiting intestinal surgery. See Table 1 for a chrono-
logical display of this patient’s serum sodium level, urine 
sodium level, and weight.
Discussion
These 4 cases illustrate unintentional weight loss, despite an 
estimated adequate caloric intake, that was associated with a 
urine sodium level ≤10 mmol/L in the presence of sodium 
losses via ileostomy. With sodium supplementation, all patients 
demonstrated weight gain and an improved urine sodium level. 
All instances of weight gain corresponded with a urine sodium 
level >10 mmol/L, with the exception of 1 occurrence in case 
1 when a weight gain of 1.2 kg occurred with a urine sodium 
level of 10 mmol/L. However, the patient could have been 
nearing TBSD, with weight yet unaffected as seen by a 3.2-kg 
weight loss the following month.
The connection between TBSD and FTT has been well 
described in premature and newborn infants5,7 in whom diffi-
culty regulating sodium balance is expected. Bower et al5 
reviewed the records of 11 premature infants with ileostomies, 
6 of whom failed to gain weight despite receiving adequate 
caloric intake. All cases of growth disturbances were associ-
ated with persistent urine sodium levels <10 mmol/L, despite 
normal serum sodium levels. With the supplementation of 
sodium chloride or sodium bicarbonate directly proportional to 
the amount of ileostomy output, all 6 infants demonstrated 
weight gain and urine sodium levels >10 mmol/L. Similarly, in 
our 4 cases, serum sodium levels remained within the reference 
range and often remained stable or only mildly fluctuated, 
despite significant alterations in urine sodium levels with sup-
plementation. This supports the evidence that urine sodium is a 
superior and/or more sensitive indicator of total body stores, 
even in older children, for the detection of TBS.
Although much has been published about sodium depletion 
in patients of various ages with established ileostomies,1-3,8 there 
is a gap in the literature linking TBSD to weight loss in older 
children and adults. Our cases suggest that the relationship 
between TBSD and FTT is not exclusive to infants but rather 
extends into adolescence and possibly adulthood. Our cases are 
supported by an additional report by Tsao et al9 in which a 
56-year-old female patient with a loop jejunostomy secondary to 
Crohn’s disease and multiple bowel resections struggled with 
weight loss and high-volume stoma output despite a high caloric 
intake. She had a normal serum sodium level of 140 mmol/L but 
a random urine sodium level of 10 mmol/L. After treatment with 
a glucose-saline solution containing 90 mEq/L, she demon-
strated an improvement in her BMI by 1.7 kg/m2.
Guidelines for the treatment of TBSD in patients with ileos-
tomies are not well defined. In cases 1, 2, and 3, patients were 
consuming an oral diet in addition to PN, making it difficult to 
determine the total sodium intake. However, when the patient 
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in case 3 first presented with weight loss and TBSD, she was 
fed almost exclusively via PN and required 9 mEq/kg of 
sodium to achieve weight gain and a urine sodium level 
>10 mmol/L. In our patient fed exclusively via enteral feeds 
(case 4), the total sodium intake was easily quantified. Weight 
gain and urine sodium levels >10 mmol/L were achieved when 
the total sodium intake was 5.3–7.5 mEq/kg/d, and weight loss 
and TBSD occurred when the total sodium intake was <2 mEq/
kg/d. Our data suggest that the optimal sodium intake for this 
patient population may be 5–10 mEq/kg/d; however, this may 
vary depending on individual daily ostomy losses. This recom-
mendation is consistent with those by Schwarz et al6,10 (6–10 
mEq/kg/d) and Bower et al5 (4–10 mEq/kg/d). We were able to 
successfully treat TBSD using parenteral and enteral routes 
and with sodium chloride and sodium bicarbonate, suggesting 
that treatment can be individualized based on clinical factors 
such as laboratory results and feeding modality. The appropri-
ate duration of supplementation is also not well established, 
but our cases suggest that ongoing supplementation may be 
necessary to maintain sodium balance, particularly in the set-
ting of high stoma output and possibly even after ileostomy 
takedown. When the patient in case 4 was hospitalized and 
sodium supplementation was discontinued, he lost weight and 
had TBSD within 2 months of discharge, suggesting that he 
would have benefitted from continuing sodium supplementa-
tion. The patient presented in case 1 lost weight and demon-
strated sodium depletion shortly after her ileostomy takedown, 
suggesting ongoing poor sodium balance and the need for con-
tinued sodium supplementation. This finding is supported by 
Schwarz et al,10 who demonstrated episodes of fluid and 
sodium depletion at 4–8 years of age in 3 children with ileosto-
mies performed in the neonatal period, followed by ileoen-
dorectal pull-throughs performed at 7–14 months of age.
The exact mechanism by which sodium depletion influences 
weight is unclear, but earlier studies have suggested ineffective 
glucose absorption due to impaired sodium-glucose cotransport 
via SGLT-1.7 However, this cannot be the only mechanism, as 
FTT associated with TBSD occurs in patients receiving full PN, 
with negligible or no oral energy intake as described in case 3. 
Additionally, TBSD can be successfully treated by supplement-
ing sodium intravenously as demonstrated in cases 3 and 4. The 
lack of anabolism due to sodium depletion may relate to a shut-
down of anabolic pathways with resultant loss of weight gain 
and protein accretion. The mechanism may also be one of the 
contributing factors that cause patients with cystic fibrosis (with 
sodium losses) to suffer from significant FTT.11,12
The possibility of confounding factors affecting changes in 
weight cannot be ruled out by these case reports. At times, 
caloric input from PN or enteral feeds was adjusted concur-
rently with sodium input, complicating the effect that sodium 
alone would have on the patient’s weight. Additionally, 3 of the 
4 patients presented consumed foods and beverages by mouth, 
causing sodium and caloric intake to vary day to day. In future 
studies looking at TBSD, all oral sodium and energy intake 
should be accounted for using daily food journals, and when 
making changes to sodium intake, caloric intake should be held 
consistent whenever possible. Noncompliance with nutrition 
support regimens also has to be considered as a contributing 
factor to fluctuations in weight. This is particularly evident in 
case 1 in which noncompliance was observed with both PN 
regimen and obtaining follow-up urine sodium levels. Lastly, 
as this is a retrospective case study, the quality of weight gain 
was not directly addressed, and it is unclear if weight gain 
reflected increased muscle mass. However, none of the labora-
tory results or documented physical examination findings indi-
cated fluid retention. In future studies, it would be beneficial to 
obtain additional anthropometric measurements, such as tri-
ceps skinfold and midarm muscle circumference, to determine 
changes in body fat and muscle mass.
Conclusion
This case report and other related studies suggest that patients 
of all ages with high stoma output should have routine urine 
sodium levels checked, particularly in the setting of weight loss 
or poor gain. In instances where sodium supplementation is 
necessary, the dose, type, and duration of treatment should be 
driven by careful and frequent monitoring of weight, ileostomy 
output, and laboratory serum and urine sodium levels. Further 
research is needed to better understand the relationship between 
TBSD and FTT and to establish intervention guidelines.
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